Related Experiment Video
Updated: Jun 19, 2026

Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
Published on: May 20, 2024
Updates and validation of the Compi RNA-seq pipeline with a case study in Alzheimer's disease
Rosalinda Di Gerlando1,2, Stella Gagliardi2, Hugo López-Fernández3
1Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.
None:
RNA-seq data analysis is a multi-step process that typically includes demultiplexing, alignment to the reference genome, read counting and genome annotation, ultimately leading to differential expression analysis (DEA). Several pipelines are currently available to support these steps and produce outputs adapted to specific experimental needs. Such pipelines must also ensure reproducibility, offer user-friendly implementation, support the analysis of complex genomes, allow batch correction, and remain sufficiently flexible to enable customization. Here , we present version 2.2 of a fully customizable command-line RNA-seq pipeline, developed within the Compi framework through the conversion and extension of the previously established DEWE graphical user interface tool. This updated version includes tasks for FASTQ quality control, two alternative read-counting strategies, and recently developed tools for DEA and pathway analysis, such as DElite and RCPA. Furthermore, we apply the pipeline to an exploratory RNA-seq study comparing transcriptomic profiles of Alzheimer's disease (AD) patients with healthy controls (HC) to identify putative disease molecular signatures and assess the pathways affected by the disease.
More Related Videos
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...